{Reference Type}: Journal Article
{Title}: COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review.
{Author}: Hassanzadeh S;Suleiman A;Correia JJ;Montazerin SM;
{Journal}: Infez Med
{Volume}: 32
{Issue}: 1
{Year}: 2024
暂无{DOI}: 10.53854/liim-3201-1
{Abstract}: Takotsubo cardiomyopathy (TTC) is a severe, acute, reversible, and self-limited cardiac dysfunction. It usually affects postmenopausal women and is mostly triggered by physical or emotional stressors. Following the COVID-19 pandemic, millions of doses of different types of COVID-19 vaccines are being administered globally. There have been reports of different cardiac complications after receiving COVID-19 vaccines. To our knowledge, there have been 16 reported cases of COVID-19 vaccination-associated TTC. In this study, we first provide a brief overview of TTC and then an overview of selected reported TTC cases following COVID-19 vaccinations. It is crucial to highlight that the occurrence of TTC after vaccination does not establish a direct cause-and-effect relationship between immunization and TTC. Further investigations are necessary to examine any potential association between COVID-19 vaccines and the incidence of TTC. Additionally, the benefits of receiving COVID-19 vaccines significantly outweigh the potential risks of developing adverse events.